Dr Lalchandani Labs Limited IPO (Dr Lalchandani Labs IPO) Detail

Apr 25, 2018 - Apr 27, 2018

Incorporated in 2011, Delhi based Dr. Lalchandani Labs Limited is a provider of diagnostic and related healthcare tests. Through its integrated network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

The Company is NABL Accredited Lab and has established 5 (Five) Self-Sufficient Labs and multiple collection centers within Delhi/NCR.

The Company is managing/servicing labs at some of the leading hospitals and operating retail outlets such as-

o Primus Super Specialty Hospital, Chanakyapuri
o Nanda Hospital, Chattarpur (70 Bedded)
o Eden Hospital, East of Kailash (25 Bedded)
o East of Kailash Retail outlet
o Dr Raturi Hospital, Khatima, Uttrakhand
o Lords Day care Centre, Bhogal New Delhi
o Greater Kailash Part 1 - Retail outlet & Head office
o Lajpat Nagar 2 - Retail Flagship outlet
o Shahdra - Retail outlet
o Dwarka Sector 19 - Retail outlet
Arya Samaj Mandir Sarojini Nagar- Charitable Retail Outlet
o Arya Samaj Mandir Malviya Nagar - Charitable Retail Outlet
o Arya Samaj Mandir Kalkaji - Charitable Retail outlet
o Arya Samaj Mandir Kasturbha Nagar - Charitable Retail Outlet
o Jampur Bhawan - Charitable Retail outlet
o Laxmi Narayan Mandir Malviya Nagar - Charitable Retail Outlet

The Company has a Blood Banking services through its sister concern CPC blood bank founded by Dr. A Lalchandani himself in 1987.

Company Financials:

Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 376.39 366.45 187.16 168.93 165.22
Total Revenue 461.67 302.81 192.79 141.39 121.96
Profit After Tax 70.74 32.32 31.91 4.13 1.93

Objects of the Issue:

The Objects of the Issue are:

1. To open second major processing center (2000 sq. ft. area) in Delhi/NCR.
2. Repayment/pre-payment, in full or part, of certain borrowings availed by the Company.
3. To purchase advanced machinery and equipment.
4. To open new collection centers based on COCO model.
5. To develop E Applications and E Programs and other I.T. support system.
6. For Recruitment, Training, and Placement of staff to expand operations and other operational expenses.
7. For general corporate purposes.

Dr Lalchandani Labs IPO Details

Dr Lalchandani Labs IPO Date Apr 25, 2018 to Apr 27, 2018
Dr Lalchandani Labs IPO Face Value ₹10 per share
Dr Lalchandani Labs IPO Price ₹30 per share
Dr Lalchandani Labs IPO Lot Size 4000 Shares
Issue Size1,400,000 shares of ₹10
(aggregating up to ₹4.20 Cr)
Issue Type Fixed Price Issue IPO
Listing At BSE SME
Company Promoters

The Promoters of the Company are Mr. Arjan Lal Chandani, Mr. Mohit Lal Chandani, and Mrs. Anchal Gupta

Dr Lalchandani Labs IPO Lot Size

The Dr Lalchandani Labs IPO lot size is 4000 shares. A retail-individual investor can apply for up to 1 lots (4000 shares or ₹120,000).

Application Lots Shares Amount
Minimum 1 4000 ₹120,000
Maximum 1 4000 ₹120,000

Dr Lalchandani Labs IPO Review

Analytical testing labs segment is doing better and set for bright prospects ahead. Investors may consider investment in this reasonably priced offer for long term.

Read detail review...

New Dr Lalchandani Labs IPO Recommendation by Members

Dr Lalchandani Labs IPO Recommendations Details | Post Recommendation | Manage Recommendations

Subscribe Neutral Avoid
0 0 0

No Record Found.

Dr Lalchandani Labs IPO Subscription Status (Bidding Detail)

The Dr Lalchandani Labs IPO is subscribed 4.96 times on Apr 27, 2018 5:00:00 PM. The public issue subscribed 6.48 times in the retail category, times in the QIB category, and 3.35 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Dr Lalchandani Labs IPO Prospectus

Dr Lalchandani Labs IPO Rating

Rating:Rated 3.7 stars
Vote Here ...

Dr Lalchandani Labs IPO Listing Date

Listing Date Wednesday, May 9, 2018
BSE Script Code 541299
NSE Symbol
Listing In MT Group of Securities
ISIN INE871Z01013
IPO Price ₹30 per share
Face Value ₹10 per share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Dr Lalchandani Labs Limited
M-20 Basement
Greater Kailash-1
New Delhi 110048
Phone: 011 49057058

Dr Lalchandani Labs IPO Registrar

Cameo Corporate Services Limited

Phone: +91-44-28460390

Dr Lalchandani Labs IPO Reviews / Ratings

Dr Lalchandani Labs IPO FAQs

Dr Lalchandani Labs IPO is a SME IPO of 1,400,000 equity shares of the face value of ₹10 aggregating up to ₹4.20 Crores. The issue is priced at ₹30 per share. The minimum order quantity is 4000 Shares.

The IPO opens on Apr 25, 2018, and closes on Apr 27, 2018.

Cameo Corporate Services Limited is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

The Dr Lalchandani Labs IPO opens on Apr 25, 2018 and closes on Apr 27, 2018.

Dr Lalchandani Labs IPO lot size is 4000 Shares and the minimum order quantity is .

You can apply in Dr Lalchandani Labs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Dr Lalchandani Labs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Dr Lalchandani Labs IPO allotment status.

The Dr Lalchandani Labs IPO listing date is on Wednesday, May 9, 2018.
Open an Instant Account with Zerodha

Dr Lalchandani Labs IPO Message Board

Ranked Members List  Ranked Members List



49. Small Investor |   Link |May 24, 2018 2:41:03 PM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
whhhha today Up 7.5%
48. PAPU |   Link |May 23, 2018 12:32:25 PM
47. VIJMISHRA |   Link |May 12, 2018 12:27:46 AM
47.1. IPOANALYSIS |   Link |May 14, 2018 11:01:03 AM
sell .
fair value is 12 rs
46. SecTheta |   Link |May 10, 2018 5:16:34 PM
Manipulated Financials. CLEAR AVOID!
45. Carn Mohan |   Link |May 9, 2018 7:34:02 PM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
Never invest any ipo where lead manager will Navigant Corporate Advisors Ltd Lead Manager last 3 IPOs are trading in huge discount totly failed leadmanager.
45.1. IPOANALYSIS |   Link |May 9, 2018 10:25:03 PM
Carn Mohan I already told u before.however u can use the money to invest in dhruv to get profits and cover ur losses from this one. Next in line from navigant is sirca paints. I hope people learn lesson and not subscribe sirca at all
44. Carn Mohan |   Link |May 9, 2018 4:20:19 PM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
Navigant Corporate Advisors Ltd is not a good lead manager Loot liya
43. Small Investor |   Link |May 9, 2018 11:13:01 AM
IPO Guru IPO Guru (1600+ Posts, 900+ Likes)
Lal Lal Chand pr Nya Nya Loss dekhkr bhayo ka mood bigd gya
42. Carn Mohan |   Link |May 9, 2018 10:47:42 AM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
Sold all shares ,Lead manager very poor.
41. vikasdds |   Link |May 9, 2018 10:22:59 AM
chore hai sala
40. IPOANALYSIS |   Link |May 9, 2018 9:52:11 AM
Listed below issue price at 29.95. as predicted. Congratulation to navigant for 3 continuous listing Badly. Continental seeds then power instrumentation and this one. Next in line Is sirca paints
40.1. RAJAKUMAR |   Link |May 9, 2018 10:15:43 AM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Dhruv is Hem
40.2. IPOANALYSIS |   Link |May 9, 2018 10:20:11 AM
Laskya is funny. He doesn't know company fundamentals and hasn't studied or gone through prospectus of dhruv and is either eager to buy at good price. Dhruv will be a multibagger in long run. Lol. Keep dreaming as no-one is interested in your comments
39. RAJAKUMAR |   Link |May 9, 2018 10:03:11 AM
IPO Guru IPO Guru (1400+ Posts, 1200+ Likes)
Lower circuit 28.5
38. SecTheta |   Link |May 9, 2018 8:42:51 AM
Listing should be around 31
Let's see. Good luck!!
37. Sinewave |   Link |May 9, 2018 8:01:09 AM
IPO Mentor IPO Mentor (500+ Posts, 300+ Likes)
Listing today.

Best wishes to allottees.
36. Carn Mohan |   Link |May 9, 2018 7:14:40 AM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
Very good company easily cross Rs 60/
35. IPOANALYSIS |   Link |May 8, 2018 11:12:25 AM
Its a sell on listing day stock.
Navigant has reputation and very bad movement of all its scrip and mostly on downside
34. Carn Mohan |   Link |May 7, 2018 5:44:53 PM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
Anybody received allotted shares in D.mat account
34.1. VIJMISHRA |   Link |May 8, 2018 9:55:35 AM
Got msg but yet not credited in D-mat account
33. Carn Mohan |   Link |May 8, 2018 6:40:33 AM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
32. NIKKI |   Link |May 7, 2018 9:16:27 PM
What is the listing date?
31. VIJMISHRA |   Link |May 6, 2018 11:36:15 AM
2 Applied and 1 allotted
30. Carn Mohan |   Link |May 6, 2018 7:19:35 AM
IPO Mentor IPO Mentor (800+ Posts, 300+ Likes)
If we annualize latest earnings and attribute it on fully diluted equity post issue, then asking price is at a P/E of around 10 thus issue appears reasonably priced. As per offer document it has no listed peers. Although on the basis of scale, they are not comparable in true sense, we may consider main board peers like Thyrocare, Dr. Lal Path that are trading at a P/E of around 38 and 43 (as on 18.04.18 closing).